KLP Kapitalforvaltning AS Has $61 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

KLP Kapitalforvaltning AS boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 123,162 shares of the medical equipment provider's stock after acquiring an additional 3,600 shares during the quarter. KLP Kapitalforvaltning AS's holdings in Intuitive Surgical were worth $60,998,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of ISRG. Brighton Jones LLC increased its holdings in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after purchasing an additional 731 shares during the period. Bank Pictet & Cie Europe AG increased its stake in shares of Intuitive Surgical by 0.5% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after buying an additional 883 shares during the period. Hillsdale Investment Management Inc. raised its holdings in Intuitive Surgical by 40.1% in the fourth quarter. Hillsdale Investment Management Inc. now owns 699 shares of the medical equipment provider's stock valued at $365,000 after acquiring an additional 200 shares in the last quarter. LPL Financial LLC lifted its stake in Intuitive Surgical by 10.5% in the fourth quarter. LPL Financial LLC now owns 364,191 shares of the medical equipment provider's stock worth $190,883,000 after acquiring an additional 34,487 shares during the last quarter. Finally, Crowley Wealth Management Inc. acquired a new position in Intuitive Surgical during the 4th quarter worth approximately $86,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on ISRG shares. Truist Financial raised their price objective on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday. Citigroup reaffirmed a "buy" rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Robert W. Baird dropped their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Barclays cut their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price target for the company from $515.00 to $440.00 in a report on Monday, June 9th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average target price of $592.05.

Insider Transactions at Intuitive Surgical

In related news, Director Jami K. Nachtsheim sold 2,400 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the sale, the director owned 6,371 shares of the company's stock, valued at $3,312,920. This trade represents a 27.36% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president owned 907 shares in the company, valued at approximately $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,298 shares of company stock valued at $1,739,171. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Up 0.7%

Shares of Intuitive Surgical stock traded up $3.66 on Friday, hitting $492.27. The company's stock had a trading volume of 943,644 shares, compared to its average volume of 1,987,069. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The firm has a fifty day moving average price of $531.22 and a 200-day moving average price of $535.38. The company has a market capitalization of $176.44 billion, a P/E ratio of 68.71, a price-to-earnings-growth ratio of 5.32 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the prior year, the company earned $1.78 EPS. The company's revenue was up 21.4% on a year-over-year basis. As a group, analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.